 The goal trial is a pragmatic, multi-center, open-label, superiority, cluster-randomized controlled trial designed to evaluate the effectiveness of comprehensive geriatric assessment, CGA, in improving the quality of life and survival of frail older adults with chronic kidney disease, CKD. The trial will involve 16 clusters, each consisting of 16 participants, and will measure the impact of CGA on goal achievement, quality of life, frailty, transfer to residential aged care facilities, cost-effectiveness, and safety of course specific hospitalizations, mortality. This article was authored by B. Logan, A. K. Vacelli, D. W. Johnson, and others.